References
- Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74–108.
- Haddad RI, Shin DM. Recent advances in head and neck cancer. N Engl J Med 2008;359:1143–54.
- Argiris A, Karamouzis MK, Raben D, Ferris RL. Head and neck cancer. Lancet 2008;371:1695–709.
- Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefebvre J-L, Greiner RH, Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer. N Engl J Med 2004;350:1945–52.
- Cooper JS, Pajak TF, Forastiere AA, Jacobs J, Campbell BH, Saxman SB, Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of head and neck. N Engl J Med 2004;350:1937–44.
- Forastiere AA, Goepfert H, Maor M, Pajak TF, Weber R, Morrison W, Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer. N Engl J Med 2003;349:2091–8.
- Pignon JP, Bourhis J, Domenge C, Designe L, on behalf of the MACH-NC collaborative group. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. Lancet 2000;355:949–55.
- Pignon JP, le Maitre A, Maillard E, Bourhis J, on behalf of the MACH-NC collaborative group. Met-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trial s and 17,346 patients. Radiother Oncol 2009;92:4–14.
- Adelstein DJ, Li Y, Adams GL, Wagner H Jr, Kish JA, Ensley JF, An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 2003;21:92–8.
- Adelstein DJ, Saxton JP, Rybicki LA, Esclamdo RM, Wood BG, Strome M, Multiagent concurrent chemoradiotherapy for locoregionally advanced squamous cell head and neck cancer: mature results from a single institution. J Clin Oncol 2006;24:1061–71.
- Denis F, Garaud P, Bardet E, Alfonsi M, Sire C, Germain T, Final results of the 94-01 French head and neck oncology and radiotherapy group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol 2004;22:69–76.
- Forest VI, Nguyen-Tan PF, Tabet JC, Olivier MJ, Larochelle D, Fortin B, Role of neck dissection following concurrent chemoradation for advanced head and neck carcinoma. Head Neck 2006;28:1099–105.
- Fakhry C, Westra WH, Li S, Cmelak A, Ridge JA, Pinto H, Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. J Natl Cancer Inst 2008;100:261–9.
- Traynor AM, Richards GM, Hartiq GK, Khuntia D, Cleary JF, Wiederholt PA, Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: the University of Wisconsin experience. Head Neck 2010;32:599–606.
- Rades D, Fehlauer F, Shiekh-Sarraf M, Kazic N, Basic H, Poorter R, Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer. Head Neck 2008;30:235–41.
- Rades D, Kronemann S, Meyners T, Bohlen G, Tribius S, Kazic N, Comparison of four cisplatin-based radiochemotherapy regimens for nonmetastatic stage III/IV squamous cell carcinoma of head and neck. Int J Radiat Oncol Biol Phys 2011;80:1037–44.
- Quintela-Fandino M, Hitt R, Medina PP, Gamarra S, Manso L, Cortes-Funes H, DNA-repair gene polymorphisms predict favorable outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy. J Clin Oncol 2006;24:4333–9.
- Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, Radiotherapy plus cetuximab for squamous cell carcinoma of head and neck. N Engl J Med 2006;354:567–78.